STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance

Tianye Li(Second Affiliated Hospital of Zhejiang University), Jianwei Zhou(Nanjing Medical University)
Frontiers in Immunology
March 14, 2024
Cited by 31


Related Papers